That’s the thing, revenue is growing, the business looks great but they keep raising capital. They are not looking at it from a shareholders point of view. Another classic example is EVS, same sorta story….company kicking goals but just getting diluted more and more. Where is the value creation for shareholders ???
- Forums
- ASX - By Stock
- CCR
- Ann: Chairman's address to the EGM
Ann: Chairman's address to the EGM, page-10
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CCR (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $134.5M |
Open | High | Low | Value | Volume |
33.0¢ | 33.0¢ | 32.0¢ | $1.005K | 3.097K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 14895 | 32.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.0¢ | 11010 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14895 | 0.320 |
1 | 21954 | 0.310 |
1 | 20000 | 0.305 |
1 | 10000 | 0.300 |
1 | 3473 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.330 | 11010 | 2 |
0.335 | 96039 | 1 |
0.340 | 43458 | 1 |
0.350 | 86234 | 1 |
0.355 | 111105 | 1 |
Last trade - 11.52am 12/11/2024 (20 minute delay) ? |
Featured News
CCR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online